J H Jacob

1.3k total citations
27 papers, 915 citations indexed

About

J H Jacob is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, J H Jacob has authored 27 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 13 papers in Oncology. Recurrent topics in J H Jacob's work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Esophageal Cancer Research and Treatment (11 papers). J H Jacob is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Esophageal Cancer Research and Treatment (11 papers). J H Jacob collaborates with scholars based in France, Luxembourg and Belgium. J H Jacob's co-authors include Jean‐Luc Raoul, B Paillot, Yacine Merrouche, Harry Bleiberg, Étienne Dorval, M. Boisdron‐Celle, G. Piot, Denis Pezet, R. Delva and Alain Morel and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J H Jacob

27 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J H Jacob France 14 508 504 473 103 64 27 915
Harald Puhalla Austria 16 478 0.9× 306 0.6× 362 0.8× 127 1.2× 109 1.7× 38 697
Arto Saarela Finland 13 407 0.8× 338 0.7× 294 0.6× 69 0.7× 36 0.6× 23 561
S. Zironi Italy 10 366 0.7× 267 0.5× 503 1.1× 52 0.5× 45 0.7× 24 665
Yvonne Lassere United States 14 205 0.4× 320 0.6× 761 1.6× 146 1.4× 69 1.1× 20 887
Soo Han Jun South Korea 17 793 1.6× 307 0.6× 1.1k 2.2× 58 0.6× 27 0.4× 20 1.2k
María José Safont Spain 16 488 1.0× 325 0.6× 865 1.8× 105 1.0× 111 1.7× 61 1.0k
R. Wong Japan 2 202 0.4× 259 0.5× 804 1.7× 69 0.7× 155 2.4× 2 892
M Findlay United Kingdom 6 361 0.7× 659 1.3× 511 1.1× 106 1.0× 21 0.3× 8 890
Marisa Di Seri Italy 9 341 0.7× 260 0.5× 631 1.3× 94 0.9× 246 3.8× 13 943
Domenico Corsi Italy 13 568 1.1× 258 0.5× 936 2.0× 58 0.6× 80 1.3× 58 1.1k

Countries citing papers authored by J H Jacob

Since Specialization
Citations

This map shows the geographic impact of J H Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J H Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J H Jacob more than expected).

Fields of papers citing papers by J H Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J H Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J H Jacob. The network helps show where J H Jacob may publish in the future.

Co-authorship network of co-authors of J H Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of J H Jacob. A scholar is included among the top collaborators of J H Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J H Jacob. J H Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacob, J H, Martin Henriksson, & Daniel Brattström. (2010). PCN100 COST-EFFECTIVENESS OF GEFITINIB VERSUS DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN. Value in Health. 13(7). A270–A270. 3 indexed citations
2.
3.
Dupuis, Olivier, Brigitte Vié, Gérard Lledo, et al.. (2007). Preoperative Treatment Combining Capecitabine with Radiation Therapy in Rectal Cancer: A GERCOR Phase II Study. Oncology. 73(3-4). 169–176. 24 indexed citations
4.
Michel, Pierre, Antoine Adenis, F. Di Fiore, et al.. (2006). Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. British Journal of Cancer. 95(6). 705–709. 38 indexed citations
5.
Bennouna, Jaafar, Hervé Perrier, B Paillot, et al.. (2005). ‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’. British Journal of Cancer. 94(1). 69–73. 20 indexed citations
6.
Dupuis, Olivier, Brigitte Vié, Gérard Lledo, et al.. (2004). Capecitabine (X) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: A phase II GERCOR trial. Journal of Clinical Oncology. 22(14_suppl). 3538–3538. 4 indexed citations
7.
Fallik, David, Marc Ychou, J H Jacob, et al.. (2003). Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer. Annals of Oncology. 14(6). 856–863. 22 indexed citations
8.
Ychou, Marc, Jean‐Luc Raoul, Françoise Desseigne, et al.. (2002). High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 50(5). 383–391. 40 indexed citations
9.
Seitz, Jean‐François, et al.. (2001). Carcinoma of the oesophagus. British Journal of Cancer. 84(s2). 61–64. 2 indexed citations
10.
Wobbes, Th., B. Barón, B Paillot, et al.. (2001). Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. European Journal of Cancer. 37(4). 470–477. 30 indexed citations
11.
Delcambre, Corinne, J H Jacob, Didier Pottier, et al.. (2001). Localized squamous-cell cancer of the esophagus: retrospective analysis of three treatment schedules. Radiotherapy and Oncology. 59(2). 195–201. 16 indexed citations
12.
Bennouna, Jaafar, J.F. Seitz, B Paillot, et al.. (1999). ‘Tomudex’ (raltitrexed) plus oxaliplatin (Eloxatin) in previously untreated metastatic colorectal cancer (MCRC) patients: an active combination. European Journal of Cancer. 35. S75–S75. 3 indexed citations
13.
Bleiberg, Harry, Thierry Conroy, B Paillot, et al.. (1997). Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. European Journal of Cancer. 33(8). 1216–1220. 235 indexed citations
14.
Conroy, Thierry, Pierre-Luc Etienne, Antoine Adenis, et al.. (1996). Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.. Journal of Clinical Oncology. 14(1). 164–170. 68 indexed citations
15.
Jacob, J H, Aart Brutel de la Rivière, A.M. Mandard, et al.. (1993). Prevalence survey of precancerous lesions of the oesophagus in a high-risk population for oesophageal cancer in France. European Journal of Cancer Prevention. 2(1). 53–60. 11 indexed citations
16.
Roussel, Alexandre, Harry Bleiberg, O. Dalesio, et al.. (1989). Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: Final results of a controlled clinical trial. International Journal of Radiation Oncology*Biology*Physics. 16(1). 67–72. 32 indexed citations
17.
Roussel, Alexandre, J H Jacob, P Haegèle, et al.. (1988). Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Recent results in cancer research. 110. 21–29. 16 indexed citations
18.
Raucourt, D. De, F. Blanchet, J. Eduardo Rame, et al.. (1985). [Screening for cancer of the upper aerodigestive tract in a high-risk population].. PubMed. 86(5). 348–51. 1 indexed citations
19.
Herlin, Paulette, et al.. (1985). Histology and ultrastructure of the human esophageal epithelium. I. Normal and parakeratotic epithelium.. PubMed. 17(4). 651–65. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harald Puhalla Breakdown of academic impact, for papers by Arto Saarela Breakdown of academic impact, for papers by S. Zironi Breakdown of academic impact, for papers by Yvonne Lassere Breakdown of academic impact, for papers by Soo Han Jun Breakdown of academic impact, for papers by María José Safont Breakdown of academic impact, for papers by R. Wong Breakdown of academic impact, for papers by M Findlay Breakdown of academic impact, for papers by Marisa Di Seri Breakdown of academic impact, for papers by Domenico Corsi
Rankless by CCL
2026